These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6488028)

  • 1. [3H]Kainic acid binding and choline acetyltransferase activity in Alzheimer's dementia.
    Pearce BR; Bowen DM
    Brain Res; 1984 Sep; 310(2):376-8. PubMed ID: 6488028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntington's disease and its animal model: alterations in kainic acid binding.
    Beaumont K; Maurin Y; Reisine TD; Fields JZ; Spokes E; Bird ED; Yamamura HI
    Life Sci; 1979 Feb; 24(9):809-16. PubMed ID: 156298
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential alterations in adenosine A1 and kappa 1 opioid receptors in the striatum in Alzheimer's disease.
    Ikeda M; Mackay KB; Dewar D; McCulloch J
    Brain Res; 1993 Jul; 616(1-2):211-7. PubMed ID: 8395303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
    Pearce BR; Palmer AM; Bowen DM; Wilcock GK; Esiri MM; Davison AN
    Neurochem Pathol; 1984-1985 Winter; 2(4):221-32. PubMed ID: 6085697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding of [3H]kainic acid to receptor sites in rat brain.
    London ED; Coyle JT
    Mol Pharmacol; 1979 May; 15(3):492-505. PubMed ID: 492142
    [No Abstract]   [Full Text] [Related]  

  • 6. Kainic acid binding to membranes of striatal neurons.
    Vincent SR; McGeer EG
    Life Sci; 1979 Jan; 24(3):265-70. PubMed ID: 423705
    [No Abstract]   [Full Text] [Related]  

  • 7. Kainic acid binding in human caudate nucleus: effect of Huntington's disease.
    Henke H
    Neurosci Lett; 1979 Oct; 14(2-3):247-51. PubMed ID: 161000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease.
    London ED; Yamamura HI; Bird ED; Coyle JT
    Biol Psychiatry; 1981 Feb; 16(2):155-62. PubMed ID: 6452910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased affinity of choline acetyltransferase for choline in Alzheimer's disease: a steady-state kinetic study.
    Nordström O; Eliaz M; Bartfai T; Gottfries CG
    Brain Res; 1987 Sep; 420(2):371-4. PubMed ID: 3676768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.
    Greenamyre JT; Penney JB; Young AB; D'Amato CJ; Hicks SP; Shoulson I
    Science; 1985 Mar; 227(4693):1496-9. PubMed ID: 2858129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.
    Nagai T; McGeer PL; Peng JH; McGeer EG; Dolman CE
    Neurosci Lett; 1983 Apr; 36(2):195-9. PubMed ID: 6866327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of receptors for kainic acid on neurons in the innernuclear layer of retina.
    Biziere K; Coyle JT
    Neuropharmacology; 1979 Apr; 18(4):409-13. PubMed ID: 450206
    [No Abstract]   [Full Text] [Related]  

  • 13. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
    Bird TD; Stranahan S; Sumi SM; Raskind M
    Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer type.
    Rossor MN; Rehfeld JF; Emson PC; Mountjoy CQ; Roth M; Iversen LL
    Life Sci; 1981 Jul; 29(4):405-10. PubMed ID: 7278494
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of choline acetyltransferase from normal and Alzheimer brain.
    Bruce G
    Neurosci Lett; 1985 Aug; 59(2):171-5. PubMed ID: 4058790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A correlative study of calcium channel antagonist binding and local neuropathological features in the hippocampus in Alzheimer's disease.
    Ikeda M; Dewar D; McCulloch J
    Brain Res; 1992 Sep; 589(2):313-9. PubMed ID: 1327415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease.
    Yates CM; Simpson J; Gordon A
    Neurosci Lett; 1986 Apr; 65(2):189-92. PubMed ID: 2940479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile.
    Nordberg A; Nyberg P; Adolfsson R; Winblad B
    J Neural Transm; 1987; 69(1-2):19-32. PubMed ID: 3585318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High affinity hippocampal [3H]-glibenclamide binding sites are preserved in Alzheimer's disease.
    Ikeda M; Dewar D; McCulloch J
    J Neural Transm Park Dis Dement Sect; 1993; 5(3):177-84. PubMed ID: 8369099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.
    Ruberg M; Ploska A; Javoy-Agid F; Agid Y
    Brain Res; 1982 Jan; 232(1):129-39. PubMed ID: 7055689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.